40
Quiver Holdings raises $3M in first biotech capital round under Reg D
Company raise · Open-ended · CAMBRIDGE, MA · Form D filed 2026-10-21
Quiver Holdings, a Delaware biotech corporation incorporated in 2023, has raised $3M from four investors in its initial offering under Regulation D exemption 6(b). The Cambridge-based company filed its first Form D on October 21, 2026, with an indefinite offering amount remaining open.
Note: First-time EDGAR filer; no placement agent listed despite capital raise; indefinite offering amount suggests ongoing fundraising intent.
First raise on EDGARoperating_company
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Graham T Dempsey | Chief Executive Officer |
| David Liederbach | President |
| David Margulies | Treasurer and Vice President |
| Paul Roma | Secretary; Chairman of the Board |
| Jonathan Fleming | Director |
| Janet Foutty | Director |
| Paul Black | Director |
Signed by Graham T. Dempsey, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.